Modulight Arranges the International Photodynamic Association (IPA) World Congress 2023 In Tampere, Finland

Modulight Corporation will organize the International Photodynamic Association’s (IPA) biennial World Congress in year 2023. The photodynamic therapy congress is a meeting place for medical researchers and clinicians to share ideas, research publications, and new discoveries in the field of medicine and technology. IPA-2023 will be held in Modulight’s home town Tampere from 10th to 15th July 2023. The congress will bring about 500 leading photodynamic therapy (PDT) experts, clinicians, researchers and industrial partners to Tampere. IPA-2023 will be held in Tampere Hall. “We are Continue reading →Modulight Corporation will organize the International Photodynamic Association's (IPA) biennial World Congress in year 2023. The photodynamic therapy congress is a meeting place for medical researchers and clinicians to share ideas, research publications, and new discoveries in the field of medicine and technology. IPA-2023 will be held in Modulight's home town Tampere from 10th to 15th July 2023. The congress will bring about 500 leading photodynamic therapy (PDT) experts, clinicians, researchers and industrial partners to Tampere. IPA-2023 will be held in Tampere Hall. "We are Continue reading →

Modulight releases 9xx nm diode laser platform for pumping

Palo Alto, California & Tampere FINLAND, 26th February 2021 – Modulight, Inc., a leading biomedical & semiconductor laser manufacturer, will release new product platforms at Photonics West 2021. There is increasing demand for higher brightness, higher efficiency and reliable components for fiber lasers in material processing. To address the demand Modulight, who has 20 years of experience with high power pump lasers, is releasing new 9xxnm high power diode laser platforms targeted especially for fiber laser pumping. New diode platforms are optimized for high brightness, high efficiency and lower operating voltage. Continue reading →

Information regarding COVID-19

Palo Alto, California & Tampere FINLAND, 19th March 2020 – Modulight, Inc. Dear Friends of Modulight laser family,Palo Alto, California & Tampere FINLAND, 19th March 2020 – Modulight, Inc. Dear Friends of Modulight laser family, We hope you and your loved ones are staying healthy and safe, despite the dramatic, ongoing COVID-19 pandemic. Modulight is also affected by COVID-19, like many other companies, and in the following we would like to inform you about our status. Modulight operations Modulight laser fab can be operated almost in a vacuum for months despite what happens around us, with little or no external supplies. Our laser process recycles Continue reading →

Seppo Orsila nominated as CEO of Modulight

Palo Alto, California & Tampere FINLAND, 10th September 2019 – Modulight, Inc., a leading biomedical & semiconductor laser manufacturer, announced today nomination of Mr. Seppo Orsila as President & Chief Executive Officer. Mr. Orsila’s nomination is effective immediately. Dr. Petteri Uusimaa will simultaneously move to new role as Vice President, Chief Technology Officer of Modulight, Inc. The changes in leadership are part of continuous development as company continues to progress at accelerating pace. Dr. Uusimaa and Mr. Orsila continue to lead the company jointly as business partners and the largest Continue reading →

Modulight becomes exclusive supplier for BAUSCH + LOMB

BRIDGEWATER, N.J., December 04, 2018 – Bausch + Lomb, a leading global eye health company, and Modulight, Inc., a designer and manufacturer of lasers and optics for personalized medicine, announced the companies have entered into an exclusive agreement to collaborate and develop a new photodynamic laser specifically designed for use with Bausch + Lomb’s VISUDYNE® (verteporfin for injection) therapy. “Photodynamic therapy continues to be an important option for eye care professionals who treat choroidal neovascularization in patients who suffer from persistent disease activity, but the availability of lasers capable Continue reading →

Jyrki Liljeroos appointed as Senior Advisor for Modulight Board

Palo Alto, California & Tampere FINLAND, April 3, 2017 – Modulight, Inc., a leading biomedical laser manufacturer, announced nomination of Mr. Jyrki Liljeroos as a senior advisor to Board of Directors today. Mr. Liljeroos’s nomination is effective from 1st April, 2017. He will work with company’s board in all aspects of the business and bring his extensive experience to Modulight. Mr. Liljeroos has a wide experience on pharmaceutical and healthcare industries, and business strategy. He has been the CEO and Executive Chairman of Santen Finland for 20 years. Mr. Liljeroos has Continue reading →

Modulight releases a biomedical illumination system

San Jose, California & Tampere FINLAND, February 16, 2016 – Modulight, Inc., a leading biomedical laser manufacturer, announces today a biomedical illumination system ML8500. ML8500 – biomedical illumination system works seamlessly with Modulight’s ML7710 medical laser or optional internal ML6xxx series lasers. Operating the illumination system is very easy with an intuitive touch-screen interface and a programming through simple Excel® spreadsheet. ML8500 is a great tool for sequential illumination of multi-well sample plates and optional fluoresence imaging/measurement. Fully automatic system takes care of the rest. The product will also offer a Continue reading →

Rising star in immunotherapy

San Jose, California & Tampere FINLAND, September 15, 2015 – Modulight, Inc., a leading biomedical laser manufacturer, announces today a rising star in immunotherapy competition. The objective is to help clinicians and biomedical researchers below 35 years old to get their hands on the best possible tools to support photo immunotherapy. All clinicians, residents and biomedical researchers worldwide are eligible to participate the contest by submitting their application via web (research plan, CV and publication list). Final selection of the winner will be done by an independent board of Continue reading →

Modulight launches the world’s first multi indication CE and ETL certified medical laser

Tampere, January 28, 2015 – Modulight, Inc., a leading biomedical laser manufacturer announced today ML7710 laser platform launch and certification. Unlike other lasers in the industry Modulight ML7710 has been certified and supports a wide range of indications and configurations. Medical CE and ETL marking are valid for all multi-channel (1–8 outputs) laser configurations between 400–2000nm and up to 15W vs. typical application and wavelength specific support. ML7710 supports directly several laser based treatment modalities, like photodynamic therapy (PDT), laser surgery, photo disinfection, and photo coagulation. This saves Continue reading →

Modulight ML7710-PDT laser platform CB testing completed

Tampere, Finland, September 09, 2014 – Modulight, Inc., an ISO13485 certified laser manufacturer based in Tampere, Finland and San Jose CA, announced today a landmark in medical laser technology. For the first time medical companies can purchase a multi-wavelength turnkey laser system with all design and hardware documentation ready for CE certification or FDA approval through PMA or 510(k) process. The CB certified laser system is also offered as a private label turnkey solution with a possibility for customized treatment protocols. ML7710-PDT product platform has been certified against Continue reading →